Our Mission
Puma Biotechnology is a biopharmaceutical company dedicated to the acquisition, development, and commercialization of novel therapeutics for the treatment of cancer.
News Releases
Year
News Releases
- Dec. 9, 2011 - Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium Read
- Nov. 23, 2011 - Puma Biotechnology Announces Completion of Private Placement Read
- Oct. 5, 2011 - Puma Biotechnology Announces Licensing Agreement with Pfizer Read